NCT05824949

Brief Summary

A total of 80 implants were placed in the posterior region of the maxilla in 40 patients in a split-mouth design. Bone quality was classified into type I, II, III, IV, or V as assessed preoperatively on cone-beam computed tomography (CBCT) . Primary implant stability was measured with insertion torque and resonance frequency analysis (ISQ values). Secondary stability was measured by ISQ at abutment installation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 4, 2022

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2022

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2023

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

April 10, 2023

Completed
14 days until next milestone

First Posted

Study publicly available on registry

April 24, 2023

Completed
Last Updated

April 24, 2023

Status Verified

April 1, 2023

Enrollment Period

2 months

First QC Date

April 10, 2023

Last Update Submit

April 20, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Mechanical or primary stability

    ISQ values at implant installation

    directly after implant placement

  • Biological or secondary stability

    ISQ values at abutment connection

    4 months after implant installation

Secondary Outcomes (1)

  • Torque value (N/cm)

    directly after implant insertion

Study Arms (2)

Osseodensification (test) group

EXPERIMENTAL

installation of 40 implants using the osseodensification protocol + measurement of implant stability (ISQ)

Procedure: osseodensification drilling

Conventional (control) group

ACTIVE COMPARATOR

installation of 40 implants using the conventional drilling protocol + measurement of implant stability (ISQ)

Procedure: conventional drilling

Interventions

Implant mechanical and biological stability measured using ISQ values at the time of implant placement and at abutment connection for 40 implants placed in the posterior maxillary area using the osseodensification protocol.

Osseodensification (test) group

Implant mechanical and biological stability measured using ISQ values at the time of implant placement and at abutment connection for 40 implants placed in the posterior maxillary area using the conventional drilling protocol.

Conventional (control) group

Eligibility Criteria

Age19 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • (a) Bilateral edentulism in the maxillary posterior region dating back more than 6 months,
  • (b) sufficient bone height (distance between the bone crest and maxillary sinus \>8 mm) and width at the alveolar crest (≥6 mm) that would not necessitate bone augmentation,
  • (c) at least 2 mm vestibular keratinized mucosa width and 3 mm mucosa thickness,
  • (d) full-mouth plaque and bleeding scores \<20%.

You may not qualify if:

  • patients with systemic diseases, conditions, or used medications having the potential to impair surgery, bone, and wound healing dynamics (such as diabetes) will be excluded.
  • patients who are allergic to antibiotics and non-steroidal anti-inflammatory drugs
  • bone height \<8mm
  • ridge and soft tissue deficiencies requiring augmentation procedures and
  • endodontic or periodontal lesions neighboring the edentulous sites will be also excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mahmoud Abu-Ta'a

Ramallah, Palestinian Territories

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

April 10, 2023

First Posted

April 24, 2023

Study Start

April 4, 2022

Primary Completion

June 1, 2022

Study Completion

February 1, 2023

Last Updated

April 24, 2023

Record last verified: 2023-04

Locations